In the journey to outperform the market, investors delve into the art of stock selection. Choosing the right stocks can be a powerful driver for wealth accumulation.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
In the latest session, Denali Therapeutics Inc (NASDAQ: DNLI) closed at $20.61 down -3.33% from its previous closing price of $21.32. In other words, the price has decreased by -$3.33 from its previous closing price. On the day, 0.6 million shares were traded. DNLI stock price reached its highest trading level at $21.625 during the session, while it also had its lowest trading level at $20.495.
Ratios:
For a deeper understanding of Denali Therapeutics Inc’s stock, let’s take a closer look at its various ratios. For the most recent quarter (mrq), Quick Ratio is recorded 9.98 and its Current Ratio is at 9.98. In the meantime, Its Debt-to-Equity ratio is 0.04 whereas as Long-Term Debt/Eq ratio is at 0.03.
Insider Transactions:
Additionally, insider trades can be beneficial to investors who want to learn what the management thinks about stock prices in the future. A recent insider transaction in this stock occurred on Nov 11 ’24 when Schenkein David P sold 59,441 shares for $32.51 per share. The transaction valued at 1,932,665 led to the insider holds 9,220 shares of the business.
Schuth Alexander O. sold 15,558 shares of DNLI for $465,286 on Nov 07 ’24. The COFO and Secretary now owns 178,066 shares after completing the transaction at $29.91 per share. On Nov 07 ’24, another insider, SATO VICKI L, who serves as the Director of the company, sold 1,020 shares for $30.00 each. As a result, the insider received 30,600 and left with 111,056 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, DNLI now has a Market Capitalization of 2966232576 and an Enterprise Value of 2182233600.
Stock Price History:
Over the past 52 weeks, DNLI has reached a high of $33.33, while it has fallen to a 52-week low of $14.56. The 50-Day Moving Average of the stock is -18.75%, while the 200-Day Moving Average is calculated to be -10.72%.
Shares Statistics:
For the past three months, DNLI has traded an average of 817.82K shares per day and 1133200 over the past ten days. A total of 143.84M shares are outstanding, with a floating share count of 124.63M. Insiders hold about 13.40% of the company’s shares, while institutions hold 88.48% stake in the company. Shares short for DNLI as of 1734048000 were 7464110 with a Short Ratio of 9.13, compared to 1731628800 on 7098359. Therefore, it implies a Short% of Shares Outstanding of 7464110 and a Short% of Float of 6.0700003.
